RPRX

Royalty Pharma PLC

Price

$58.72

return (12m)

66.23%

p/e

31.15

p/bv

2.59

DIVIDEND YIELD

1.55%

RPRX price

Royalty Pharma

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment RPRX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

9.61%

3 months

18.87%

1 year

66.23%

2 years

117.03%

5 years

66.45%

10 years

0.00%

Fundamentals RPRX

Valuation

P/E

31.15

Sector -102.92

Industry 11.81

P/BV

2.59

Sector -6.44

Industry 1.73

P/Revenue (PSR)

10.56

Sector 1.28

Industry 1.60

EV/EBITDA

58.53

Sector -

Industry -

EV/EBIT

58.65

Sector -

Industry -

P/EBITDA

15.16

Sector -66.33

Industry 7.22

P/EBIT

15.20

Sector -67.91

Industry 7.79

P/Total Assets

1.30

Sector 0.13

Industry 0.51

P/Ativo Circ. Liq.

-3.05

Sector -

Industry -

P/Cap.Giro

28.96

Sector -

Industry -

EPS

1.89

Sector -9,518.40

Industry 11.93

BVPS

22.74

Sector -3,877.08

Industry 63.17

Efficiency

Gross Margin

100.00%

Sector -0.53%

Industry 2.57%

EBITDA Margin

89.31%

Sector -

Industry -

EBIT Margin

89.12%

Sector -

Industry -

Operating Margin

67.93%

Sector -5.67%

Industry 0.68%

Net Profit Margins

33.90%

Sector -0.23%

Industry 13.29%

Giro Ativos

0.03

Sector -

Industry -

Profitability

ROE

8.33%

Sector -2,898.20%

Industry 15.95%

ROA

4.18%

Sector -1,430.88%

Industry 4.46%

ROIC

13.56%

Sector -11.33%

Industry 1.17%

Dividends

Dividend yield

1.55%

Sector 0.39%

Industry 1.68%

Payout

48.28%

Sector -

Industry -

Debt

Current Ratio

2.66

Sector -

Industry -

Dívida Líquida/EBITDA

12.76

Sector -

Industry -

Dívida Líquida/EBIT

12.79

Sector -

Industry -

Dívida Líquida/Patrimônio

0.72

Sector -

Industry -

Dívida Bruta/Patrimônio

0.86

Sector -

Industry -

Equity/Assets

0.50

Sector 0.00

Industry 0.27

Liabilities/Assets

0.50

Sector 0.33

Industry 0.68

Growth

5Y Revenue CAGR

1.29%

Sector -

Industry -

5Y Earnings CAGR

5.95%

Sector -

Industry -

FAIR VALUE OF Royalty Pharma ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$58.72

Fair Value

$31.10

Upside Return potential.

-47.04%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals RPRX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
RPRX	31.15	2.59	8.33%	1.55%	$25.77 B	33.90%
JPM	14.19	2.47	17.37%	1.72%	$923.45 B	33.40%
NU	21.03	5.32	25.29%	0.00%	$66.95 B	18.14%
MA	30.94	71.66	231.63%	0.60%	$481.70 B	45.88%
BAC	13.10	1.46	11.18%	1.82%	$440.79 B	27.79%
INTR	255.55	33.19	12.99%	2.10%	$2.40 B	9.23%
BRK-B	14.69	1.46	9.94%	0.00%	$1.06 T	17.28%
HSBC	14.60	1.65	11.31%	3.94%	$325.78 B	30.81%
BRK-A	10.24	1.02	9.94%	0.00%	$742.05 B	17.28%
C	12.45	1.04	8.32%	1.84%	$222.05 B	19.56%
RY	18.84	2.95	15.67%	2.08%	$302.30 B	31.85%
BLK	25.42	0.00	-%	2.03%	$167.13 B	24.09%
PYPL	10.23	2.58	25.26%	0.74%	$51.75 B	15.00%
ING	12.54	1.56	12.43%	4.16%	$93.81 B	27.73%
PAGS	6.42	0.92	14.28%	6.79%	$2.55 B	10.41%
AXP	21.98	7.19	32.71%	0.96%	$244.38 B	13.49%
SAN	10.91	1.57	14.44%	1.50%	$204.87 B	27.40%
WFC	11.86	1.47	12.40%	2.04%	$268.12 B	26.05%
BBVA	11.38	2.03	17.87%	4.28%	$142.92 B	27.30%
XP	8.27	1.79	21.68%	2.36%	$8.45 B	29.31%
LYG	1.68	0.26	15.64%	3.34%	$89.31 B	9.85%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

RPRX Historical Dividends

current DY: 1.55%

5-year average DY: 2.51%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	05/14/2026	06/10/2026	0.24000000
Dividends	02/19/2026	03/10/2026	0.23500000
Dividends	11/13/2025	12/10/2025	0.22000000
Dividends	08/14/2025	09/10/2025	0.22000000
Dividends	05/15/2025	06/10/2025	0.22000000
Dividends	02/20/2025	03/10/2025	0.22000000
Dividends	11/14/2024	12/10/2024	0.21000000
Dividends	08/15/2024	09/13/2024	0.21000000
Dividends	05/15/2024	06/14/2024	0.21000000
Dividends	02/14/2024	03/15/2024	0.21000000
Dividends	11/15/2023	12/15/2023	0.20000000
Dividends	08/16/2023	09/15/2023	0.20000000
Dividends	05/17/2023	06/15/2023	0.20000000
Dividends	02/14/2023	03/15/2023	0.20000000
Dividends	11/16/2022	12/15/2022	0.19000000
Dividends	08/17/2022	09/15/2022	0.19000000
Dividends	05/18/2022	06/15/2022	0.19000000
Dividends	02/16/2022	03/15/2022	0.19000000
Dividends	11/17/2021	12/15/2021	0.17000000
Dividends	08/18/2021	09/15/2021	0.17000000
Dividends	05/18/2021	06/15/2021	0.17000000
Dividends	02/17/2021	03/15/2021	0.17000000
Dividends	11/18/2020	12/15/2020	0.15000000
Dividends	09/11/2020	09/30/2020	0.15000000

ABOUT Royalty Pharma

Royalty Pharma PLC

Average Investor10 user rating

4.0 (4 people)

United States

6 years

Founded: 2020

2020

Time since IPO - 6 years

-

Employees

Royalty Pharma PLC (United States) is listed on the Nasdaq and has a market capitalization of $25.77 billion, with shareholders equity totaling $9.94 billion.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, Royalty Pharma PLC reported $2.44 billion in revenue, generating net income of $827.30 million.

Key financial metrics include a P/E ratio of 31.15, a price-to-book (P/B) ratio of 2.59, and a trailing twelve-month dividend yield of 1.55%.

The company trades under the ticker RPRX.

Market cap

$25.77 billion

Net worth

$9.94 billion

$9,936,830,000.00

Assets

$19.82 billion

$19,815,420,000.00

Total Shares Outstanding

437.00 million

437,000,000

Average Daily Trading Volume

$3.86 million

$3,856,646.00

Sector

Financial

Industry

Auxiliary Activities of Financial Services

RPRX

revenue by Business Segment Royalty Pharma

Revenue by Region Royalty Pharma

RPRX revenue and profits

Financial Results RPRX

DRAG THE FRAME TO SEE MORE DATA

RPRX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BRK-A - Berkshire Hathaway

$734,000.00 1,50% (12M)

P/E

10.24

0.00%

ROE

9.94%

P/BV

1.02

BRK-B - Berkshire Hathaway

$489.39 1,40% (12M)

P/E

14.69

0.00%

ROE

9.94%

P/BV

1.46

JPM - JPMorgan

$348.21 20,18% (12M)

P/E

14.19

1.72%

ROE

17.37%

P/BV

2.47

SNEX - StoneX Group

$74.02 74,16% (12M)

P/E

26.17

0.00%

ROE

17.13%

P/BV

4.48

LYG - Lloyds Banking Group

$6.13 48,68% (12M)

P/E

1.68

3.34%

ROE

15.64%

P/BV

0.26

BAC - Bank of America

$61.62 30,81% (12M)

P/E

13.10

1.82%

ROE

11.18%

P/BV

1.46

AEG - Aegon

$9.16 31,73% (12M)

P/E

3.70

5.10%

ROE

33.99%

P/BV

1.26

C - Citigroup

$132.25 41,79% (12M)

P/E

12.45

1.84%

ROE

8.32%

P/BV

1.04

BRK-A - Berkshire Hathaway

$734,000.00 1,50% (12 M)

P/L

10.24

0.00%

ROE

9.94%

P/VP

1.02

BRK-B - Berkshire Hathaway

$489.39 1,40% (12 M)

P/L

14.69

0.00%

ROE

9.94%

P/VP

1.46

JPM - JPMorgan

$348.21 20,18% (12 M)

P/L

14.19

1.72%

ROE

17.37%

P/VP

2.47

SNEX - StoneX Group

$74.02 74,16% (12 M)

P/L

26.17

0.00%

ROE

17.13%

P/VP

4.48

LYG - Lloyds Banking Group

$6.13 48,68% (12 M)

P/L

1.68

3.34%

ROE

15.64%

P/VP

0.26

BAC - Bank of America

$61.62 30,81% (12 M)

P/L

13.10

1.82%

ROE

11.18%

P/VP

1.46

AEG - Aegon

$9.16 31,73% (12 M)

P/L

3.70

5.10%

ROE

33.99%

P/VP

1.26

C - Citigroup

$132.25 41,79% (12 M)

P/L

12.45

1.84%

ROE

8.32%

P/VP

1.04

Frequently Asked Questions

What is the price of Royalty Pharma (RPRX) today?

A cotação de Royalty Pharma (RPRX) hoje está em US$ 58.72, com uma variação de 66.23% em relação ao último ano. A cotação de Royalty Pharma (RPRX) iniciou o ano negociando na casa dos US$ 38.64 e hoje está em US$ 58.72. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Royalty Pharma (RPRX) e dados de ações do Ibovespa e mercados internacionais.

Quando Royalty Pharma (RPRX) paga dividendos?

Royalty Pharma (RPRX) distribuiu dividendos no último ano,in the months of March and June totalizando R$ 0.48. O Dividend Yield referente aos 12 últimos meses é de 1.55%.

Is Royalty Pharma (RPRX) a good investment?

Atualmente, Royalty Pharma (RPRX) está cotada a US$ 58.72, com um P/L de 31.15, representando um desvio de 8,957% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 66.23 em sua cotação e distribuiu US$ 0.48 em dividendos, resultando em um Dividend Yield de 1.55%. O retorno total do acionista foi de 66.23%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Royalty Pharma (RPRX) stock?

Investir em ações de Royalty Pharma (RPRX) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Royalty Pharma (RPRX) yield today?

A rentabilidade de Royalty Pharma (RPRX) foi de 9.61% no último mês, 66.23% no último ano e 66.45% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.92 em dividendos, um Dividend Yield de 1.55%.

Se você quisesse comprar 100 ações de Royalty Pharma (RPRX) hoje, o investimento total seria de US$ 5,872.00, com base na cotação atual de US$ 58.72.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 9,761.03
Em 5 anos: US$ 9,773.94
Em 10 anos: US$ 5,872.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

RPRX

Royalty Pharma PLC

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment RPRX

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

current DY: 1.55%

5-year average DY: 2.51%

type

Ex - Dividend Date

payment date

value

ABOUT Royalty Pharma

Royalty Pharma PLC

United States

6 years

2020

-

PROFIT X PRICE RPRX

Financial Results RPRX

RPRX cash flow

Asset, Revenue and Profit Growth - RPRX

RPRX balance sheet

BRK-A - Berkshire Hathaway

BRK-B - Berkshire Hathaway

JPM - JPMorgan

SNEX - StoneX Group

LYG - Lloyds Banking Group

BAC - Bank of America

AEG - Aegon

C - Citigroup

BRK-A - Berkshire Hathaway

BRK-B - Berkshire Hathaway

JPM - JPMorgan

SNEX - StoneX Group

LYG - Lloyds Banking Group

BAC - Bank of America

AEG - Aegon

C - Citigroup

Frequently Asked Questions